Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
出版年份 2016 全文链接
标题
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
作者
关键词
Prostate neoplasm, Inflammation, Radical prostatectomy, Radiotherapy, Hormone therapy
出版物
Journal of Inflammation-London
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-11-25
DOI
10.1186/s12950-016-0143-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer
- (2016) Young Suk Kwon et al. Clinical Genitourinary Cancer
- Cancer stem cells
- (2016) Jeremy N. Rich MEDICINE
- C-Reactive Protein is a Prognostic Marker for Patients with Castration-Resistant Prostate Cancer
- (2016) Shao-Guang Liao et al. Oncology Research and Treatment
- Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis
- (2016) Lu Tang et al. PLoS One
- Neutrophil count is associated with survival in localized prostate cancer
- (2015) Houda Bahig et al. BMC CANCER
- The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy
- (2015) Eva-Maria Thurner et al. EUROPEAN JOURNAL OF CANCER
- Inflammation and prostate cancer: friends or foe?
- (2015) Gianluigi Taverna et al. INFLAMMATION RESEARCH
- Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy
- (2015) Takuya Koie et al. International Journal of Clinical Oncology
- L-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer
- (2015) J Pencik et al. SWISS MEDICAL WEEKLY
- Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy
- (2015) Tanja Langsenlehner et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients
- (2015) Tanja Langsenlehner et al. WORLD JOURNAL OF UROLOGY
- Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells
- (2015) Pamela J. Maxwell et al. Oncotarget
- Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
- (2014) R. Leibowitz-Amit et al. ANNALS OF ONCOLOGY
- Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use
- (2014) D. Lorente et al. ANNALS OF ONCOLOGY
- Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials†
- (2014) R. J. van Soest et al. ANNALS OF ONCOLOGY
- Cancer-related inflammation: An emerging prognostic domain in metastatic castration-resistant prostate carcinoma
- (2014) David J. Pinato CANCER
- Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio
- (2014) Arnoud J. Templeton et al. CANCER
- Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
- (2014) B. Gurel et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer
- (2014) Guru Sonpavde et al. Clinical Genitourinary Cancer
- A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment
- (2014) Stuart J Ellem et al. JOURNAL OF PATHOLOGY
- Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer
- (2014) Anna Bill-Axelson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancer
- (2014) Kazutoshi Fujita et al. PROSTATE
- Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival
- (2014) Jaya Sharma et al. PROSTATE
- CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study
- (2014) Igor Tsaur et al. Cancer Research and Treatment
- The Role of M1 and M2 Macrophages in Prostate Cancer in relation to Extracapsular Tumor Extension and Biochemical Recurrence after Radical Prostatectomy
- (2014) M. Lanciotti et al. Biomed Research International
- Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer
- (2014) Raju R Raval et al. Journal for ImmunoTherapy of Cancer
- The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)
- (2013) Giorgio Gandaglia et al. BJU INTERNATIONAL
- Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer
- (2013) Daniel P. Nguyen et al. BJU INTERNATIONAL
- Infiltrating Macrophages Promote Prostate Tumorigenesis via Modulating Androgen Receptor-Mediated CCL4-STAT3 Signaling
- (2013) L.-Y. Fang et al. CANCER RESEARCH
- A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer
- (2013) J. D. Schoenfeld et al. CLINICAL CANCER RESEARCH
- Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy
- (2013) Anthony Linton et al. Clinical Genitourinary Cancer
- Chemokines and Chemokine Receptors as Promoters of Prostate Cancer Growth and Progression
- (2013) Nicole Salazar et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Mast Cells as a Potential Prognostic Marker in Prostate Cancer
- (2013) Gianluigi Taverna et al. DISEASE MARKERS
- Linking inflammation and neuroendocrine differentiation: the role of macrophage migration inhibitory factor-mediated signaling in prostate cancer
- (2013) Rosalinda M Savoy et al. ENDOCRINE-RELATED CANCER
- Intratumoral inflammation is associated with more aggressive prostate cancer
- (2013) Joseph C. Klink et al. WORLD JOURNAL OF UROLOGY
- Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells
- (2012) Thomas Tawadros et al. ENDOCRINE-RELATED CANCER
- CD4 helper T cells, CD8 cytotoxic T cells and FOXP3+ regulatory T cells with respect to lethal prostate cancer
- (2012) Sabina Davidsson et al. MODERN PATHOLOGY
- SUMO-specific protease 1 promotes prostate cancer progression and metastasis
- (2012) Q Wang et al. ONCOGENE
- CCL11 (eotaxin-1): A new diagnostic serum marker for prostate cancer
- (2012) Manisha Agarwal et al. PROSTATE
- A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study
- (2011) Michael J. Proctor et al. EUROPEAN JOURNAL OF CANCER
- The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
- (2011) Cosimo De Nunzio et al. EUROPEAN UROLOGY
- Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study
- (2011) K Shafique et al. PROSTATE CANCER AND PROSTATIC DISEASES
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
- (2010) Massimo Ammirante et al. NATURE
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- Systemic Inflammatory Response and Survival in Patients with Localised Prostate Cancer: 10-Year Follow-Up
- (2010) Peter A. McArdle et al. UROLOGIA INTERNATIONALIS
- Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach
- (2009) Calogero Caruso et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cytokine genetic polymorphisms and prostate cancer aggressiveness
- (2009) J. Zabaleta et al. CARCINOGENESIS
- Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer
- (2009) D. A. Brown et al. CLINICAL CANCER RESEARCH
- Inflammation, infection, and prostate cancer
- (2008) Eric A Klein et al. CURRENT OPINION IN UROLOGY
- Prostate growth and inflammation
- (2007) Alessandro Sciarra et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now